157 related articles for article (PubMed ID: 16796351)
1. Role of surfactant and pH on dissolution properties of fenofibrate and glipizide--a technical note.
Jamzad S; Fassihi R
AAPS PharmSciTech; 2006 Apr; 7(2):E33. PubMed ID: 16796351
[TBL] [Abstract][Full Text] [Related]
2. Osmotic pellet system comprising osmotic core and in-process amorphized drug in polymer-surfactant layer for controlled delivery of poorly water-soluble drug.
Saindane N; Vavia P
J Pharm Sci; 2012 Sep; 101(9):3169-79. PubMed ID: 22418998
[TBL] [Abstract][Full Text] [Related]
3. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note.
Gohel M; Parikh R; Brahmbhatt B; Shah A
AAPS PharmSciTech; 2007 Feb; 8(1):13. PubMed ID: 17408213
[TBL] [Abstract][Full Text] [Related]
4. Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery.
Pan H; Jing H; Yang X; Pan W; Chen T
Drug Dev Ind Pharm; 2017 May; 43(5):780-788. PubMed ID: 27278057
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of bioadhesive glipizide spheres and compacts from spheres prepared by extruder/marumerizer technique.
Garcia J; Ghaly ES
Pharm Dev Technol; 2001 Aug; 6(3):407-17. PubMed ID: 11485182
[TBL] [Abstract][Full Text] [Related]
6. Microwave-generated bionanocomposites for solubility and dissolution enhancement of poorly water-soluble drug glipizide: in-vitro and in-vivo studies.
Kushare SS; Gattani SG
J Pharm Pharmacol; 2013 Jan; 65(1):79-93. PubMed ID: 23215691
[TBL] [Abstract][Full Text] [Related]
7. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
[TBL] [Abstract][Full Text] [Related]
8. Formulation of fenofibrate liquisolid tablets using central composite design.
Patel T; Patel LD; Suhagia BN; Soni T; Patel T
Curr Drug Deliv; 2014; 11(1):11-23. PubMed ID: 24712439
[TBL] [Abstract][Full Text] [Related]
9. IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system.
Buch P; Langguth P; Kataoka M; Yamashita S
J Pharm Sci; 2009 Jun; 98(6):2001-9. PubMed ID: 18855916
[TBL] [Abstract][Full Text] [Related]
10. Surfactant-mediated dissolution of metformin hydrochloride tablets: wetting effects versus ion pairs diffusivity.
Desai D; Wong B; Huang Y; Ye Q; Tang D; Guo H; Huang M; Timmins P
J Pharm Sci; 2014 Mar; 103(3):920-6. PubMed ID: 24549733
[TBL] [Abstract][Full Text] [Related]
11. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide.
Defang O; Shufang N; Wei L; Hong G; Hui L; Weisan P
Drug Dev Ind Pharm; 2005 Aug; 31(7):677-85. PubMed ID: 16207615
[TBL] [Abstract][Full Text] [Related]
13. Selection of the most suitable dissolution method for an extended release formulation based on IVIVC level A obtained on cynomolgus monkey.
Scheubel E; Adamy L; Hoffart V; Cardot JM
Drug Dev Ind Pharm; 2010 Nov; 36(11):1320-9. PubMed ID: 20849348
[TBL] [Abstract][Full Text] [Related]
14. Computational Modeling of Polymeric Physicochemical Properties for Formulation Development of a Drug Containing Basic Functionality.
Gaikwad VL; Bhatia NM; Singhvi I; Mahadik KR; Bhatia MS
J Pharm Sci; 2017 Nov; 106(11):3337-3345. PubMed ID: 28688842
[TBL] [Abstract][Full Text] [Related]
15. Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability.
Zhang L; Chai G; Zeng X; He H; Xu H; Tang X
Drug Dev Ind Pharm; 2010 Sep; 36(9):1054-63. PubMed ID: 20818965
[TBL] [Abstract][Full Text] [Related]
16. Development of a robust once-a-day glipizide matrix system.
Jamzad S; Fassihi R
J Pharm Pharmacol; 2007 Jun; 59(6):769-75. PubMed ID: 17637169
[TBL] [Abstract][Full Text] [Related]
17. The effect of pH on the in-vitro dissolution of three second-generation sulphonylurea preparations: mechanism of antacid-sulphonylurea interaction.
Lehto P; Laine K; Kivistö KT; Neuvonen PJ
J Pharm Pharmacol; 1996 Sep; 48(9):899-901. PubMed ID: 8910849
[TBL] [Abstract][Full Text] [Related]
18. Combining in vitro and in silico methods for better prediction of surfactant effects on the absorption of poorly water soluble drugs-a fenofibrate case example.
Berthelsen R; Sjögren E; Jacobsen J; Kristensen J; Holm R; Abrahamsson B; Müllertz A
Int J Pharm; 2014 Oct; 473(1-2):356-65. PubMed ID: 24997410
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin complex osmotic tablet for glipizide delivery.
Gan Y; Pan W; Wei M; Zhang R
Drug Dev Ind Pharm; 2002 Sep; 28(8):1015-21. PubMed ID: 12378956
[TBL] [Abstract][Full Text] [Related]
20. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: a technical note.
Chowdary KP; Rao YS
AAPS PharmSciTech; 2003; 4(3):E39. PubMed ID: 14621971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
